Bionxt Solutions
  • About Us
    • About Us
    • Our Team
  • Our Products
    • Point-of-Care Diagnostics
    • Drug Delivery
    • Psychedelics
  • News
  • Investors
    • Investor Information
    • Shareholder Documents
  • Contact
XPhyto Lab Worker with protective eyewear
  • Home
  • News

Category: Press Releases

View all Posts

Show All Press Releases Diagnostics Psychedelics Drug Delivery

Press Releases

XPhyto adds Top-Level Executive Talent to its Global Operations

Apr 20, 2021

XPhyto announces the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as the...

Continue Reading

Diagnostics, Press Releases

XPhyto announces European Approval for 25 Minute COVID-19 PCR Test

Mar 18, 2021

CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2Rapid results with ease of use - single 20-minute PCR cycle plus...

Continue Reading

Diagnostics, Press Releases

XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test

Mar 10, 2021

Vancouver, Canada (March 10, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...

Continue Reading

Press Releases

Brand Launch Feature Image

XPhyto Completes Corporate Rebranding and Launches New Website

Mar 4, 2021

Vancouver, Canada (March 4, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company...

Continue Reading

Press Releases

Xphyto provides updated comments on promotional and marketing activity

Feb 26, 2021

VANCOUVER, British Columbia – February 26, 2021 – XPhyto Therapeutics Corp. (CSE: XPHY; OTC: XPHYF; FSE: 4XT) (“XPhyto” or the “Company”) at the request of...

Continue Reading

Diagnostics, Press Releases

Point of Care COVID 19 Rapid Diagnostic test

XPhyto Places First Order For 25-Minute COVID-19 RT-PCR Tests

Feb 24, 2021

Vancouver, Canada (February 24, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that it has...

Continue Reading

Diagnostics, Press Releases

XPhyto Builds Commercial Team To Launch 25-Minute COVID-19 RT-PCR Test

Feb 22, 2021

Vancouver, Canada (February 22, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company...

Continue Reading

Diagnostics, Press Releases

XPhyto European CE-IVD Application For 25-Minute COVID-19 RT-PCR Test

Feb 16, 2021

Vancouver, Canada (February 16, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...

Continue Reading

Press Releases, Psychedelics

XPhyto Adds Mescaline Production To Psychedelic Medicine Programs

Feb 10, 2021

Vancouver, Canada (February 10, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories...

Continue Reading

Press Releases, Psychedelics

Xphyto Therapeutics lab technician

XPhyto Announces Psychedelic Pharmaceutical Production Agreement

Feb 3, 2021

Vancouver, Canada (February 3, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories...

Continue Reading

Drug Delivery, Press Releases

XPhyto Announces Drug Formulation Strategy And 2021 Milestones

Jan 28, 2021

Construction of commercial drug manufacturing facility in GermanyFour clinical studies in neurological indications in 2021Development of oral biosensor and contract development & manufacturingPsychedelic transdermal and...

Continue Reading

Press Releases

XPhyto Announces Business Strategy And Milestones For 2021

Jan 18, 2021

Commercialization of rapid COVID-19 PCR testClinical validation of transdermal and sublingual drug formulationsPsychedelic API production, drug formulation and clinical integration Vancouver, Canada (January 18, 2021)...

Continue Reading
Page 4 of 8‹1234567›››
Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.

  • About Bionxt
  • Our Team
  • Our Products
  • Careers
  • Investor Information
  • Company/Investor Presentation
  • Press Releases
  • Request Info
  • Legal Information
  • Cautionary Note
  • Privacy Policy
  • Contact
Xphyto test tubes in laboratory footer
Copyright © 2023 Bionxt Solutions
This website uses cookies and third party services. By clicking “Accept”, you consent to the use of all cookies
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT